PURPOSE: Diabetes is associated with increased risk of developing colorectal cancer (CRC), but its effect on overall and cancer-specific mortality in CRC patients has been little investigated. The aim of this study was to assess the influence of diabetes on overall and cancer-specific mortality in Italian CRC patients. METHODS: Cases of adult (≥15 years) CRC, diagnosed in 2003-2005, most followed-up to the end of 2008, were randomly selected from the Italian Cancer Registries database. Diabetic status, sex, age, tumor stage, subsite, treatment, morphology, and grade were obtained by consultation of patient clinical records. Poisson multivariable regression models, adjusted for potential confounding variables, were used to estimate hazard ratios (HRs) for all-cause and CRC-specific mortality, according to diabetic status. RESULTS: A total of 1,039 CRC cases with known fasting glucose or diabetic status, archived in 7 cancer registries, was analyzed. Compared to non-diabetics, diabetics (specific diagnosis or glucose ≥126 mg/dl) were older and less likely to receive adjuvant therapy. Diabetics were at higher risk of all-cause death [HR 1.41; 95 % confidence interval (CI) 1.18-1.70] and CRC death (HR 1.36; 95 % CI 1.11-1.67), with no differences by sex or subsite. CONCLUSIONS: Diabetes was significantly associated with increased overall and CRC-specific mortality. Our findings indicate that diabetes is a negative prognostic factor for CRC and suggest that in patients with CRC, diabetes prevention and treatments that stabilize the condition and control its complications might reduce mortality. Further studies are required to ascertain the mechanisms linking diabetes to greater mortality in CRC patients.
PURPOSE:Diabetes is associated with increased risk of developing colorectal cancer (CRC), but its effect on overall and cancer-specific mortality in CRC patients has been little investigated. The aim of this study was to assess the influence of diabetes on overall and cancer-specific mortality in Italian CRC patients. METHODS: Cases of adult (≥15 years) CRC, diagnosed in 2003-2005, most followed-up to the end of 2008, were randomly selected from the Italian Cancer Registries database. Diabetic status, sex, age, tumor stage, subsite, treatment, morphology, and grade were obtained by consultation of patient clinical records. Poisson multivariable regression models, adjusted for potential confounding variables, were used to estimate hazard ratios (HRs) for all-cause and CRC-specific mortality, according to diabetic status. RESULTS: A total of 1,039 CRC cases with known fasting glucose or diabetic status, archived in 7 cancer registries, was analyzed. Compared to non-diabetics, diabetics (specific diagnosis or glucose ≥126 mg/dl) were older and less likely to receive adjuvant therapy. Diabetics were at higher risk of all-cause death [HR 1.41; 95 % confidence interval (CI) 1.18-1.70] and CRC death (HR 1.36; 95 % CI 1.11-1.67), with no differences by sex or subsite. CONCLUSIONS:Diabetes was significantly associated with increased overall and CRC-specific mortality. Our findings indicate that diabetes is a negative prognostic factor for CRC and suggest that in patients with CRC, diabetes prevention and treatments that stabilize the condition and control its complications might reduce mortality. Further studies are required to ascertain the mechanisms linking diabetes to greater mortality in CRC patients.
Authors: Nicole Annette Shonka; James R Anderson; Amit W Panwalkar; Elizabeth C Reed; Preston D Steen; Apar Kishor Ganti Journal: Med Oncol Date: 2006 Impact factor: 3.064
Authors: Valery E P P Lemmens; Maryska L G Janssen-Heijnen; Saskia Houterman; Kees D G W Verheij; Hendrik Martijn; Lonneke van de Poll-Franse; Jan Willem W Coebergh Journal: World J Surg Date: 2007-01 Impact factor: 3.352
Authors: L Roncucci; R Fante; L Losi; C Di Gregorio; A Micheli; P Benatti; N Madenis; D Ganazzi; M T Cassinadri; P Lauriola; M Ponz de Leon Journal: Eur J Cancer Date: 1996-02 Impact factor: 9.162
Authors: Steven S Coughlin; Eugenia E Calle; Lauren R Teras; Jennifer Petrelli; Michael J Thun Journal: Am J Epidemiol Date: 2004-06-15 Impact factor: 4.897
Authors: L V van de Poll-Franse; H R Haak; J W W Coebergh; M L G Janssen-Heijnen; V E P P Lemmens Journal: Diabetologia Date: 2012-04-24 Impact factor: 10.122
Authors: Jessica Chubak; Onchee Yu; Rebecca A Ziebell; Erin J Aiello Bowles; Andrew T Sterrett; Monica M Fujii; Jennifer M Boggs; Andrea N Burnett-Hartman; Denise M Boudreau; Lu Chen; James S Floyd; Debra P Ritzwoller; Rebecca A Hubbard Journal: Cancer Causes Control Date: 2018-09-22 Impact factor: 2.506
Authors: Kristin Wallace; Katherine R Sterba; Elena Gore; David N Lewin; Marvella E Ford; Melanie B Thomas; Anthony J Alberg Journal: Clin Colorectal Cancer Date: 2013-12 Impact factor: 4.481